Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations, PRS II Study
This phase III trial compares risk assessment before surgery with intensified surveillance following surgery to standard surveillance (usual care) for lowering the risk of death or serious complications in patients undergoing elective major cancer operations. Risk-based assessment before surgery and intensified post-discharge risk-based management may lower the risk of serious complications.
Inclusion Criteria
- FIRST REGISTRATION-INCLUSION
- Age >= 18 years at diagnosis ( =< 30 days prior to the index surgical procedure)
- Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 ( =< 30 days prior to the index surgical procedure)
- Patients must have probable (i.e., clinically suspicious) or histologically/cytologically confirmed, primary or recurrent, malignant neoplasm, malignant neuroendocrine tumor, or carcinoma in situ (any stage) ( =< 30 days prior to the index surgical procedure)
- Patients undergoing major operations to resect or treat known or suspected malignancies of the head and neck, chest, abdomen, genitourinary tract, or extremities are eligible. Patients undergoing biopsies, outpatient procedures, superficial resections of cutaneous malignancies, or purely palliative operations are not eligible (=< 30 days prior to the index surgical procedure) * These procedures are commonly performed in patients with malignant neoplasms, malignant neuroendocrine tumors, or carcinomas in situ, and are commonly “tracked” by hospitals and cancer centers participating in the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) procedure targeted option because they are often associated with higher rates of postoperative morbidity and mortality (compared to other, less complex cancer procedures)
- Patient must be scheduled for elective major cancer surgery at Fox Chase Cancer Center (FCCC) =< 30 days after first registration ( =< 30 days prior to the index surgical procedure) * Elective surgery is defined as: ** Patient is scheduled to be brought from their home (or normal living environment) to FCCC on the day of the index surgery (or day prior as scheduled admission) AND ** Surgery is not scheduled as urgent or emergent
- Elective surgery is defined as: * Patient is scheduled to be brought from their home (or normal living environment) to FCCC on the day of the index surgery (or day prior as scheduled admission) AND * Surgery is not scheduled as urgent or emergent ( =< 30 days prior to the index surgical procedure)
- Ability to understand and willingness to sign a written informed consent and Health Insurance Portability and Accountability Act (HIPAA) consent document ( =< 30 days prior to the index surgical procedure)
- Geographical accessibility and willingness to return to FCCC for all preoperative and postoperative study assessments ( =< 30 days prior to the index surgical procedure)
- SECOND REGISTRATION-INCLUSION
- Elective (curative or palliative) major cancer surgery occurred at the time of the index surgery (patient may have undergone more than one of these procedures) * For the purposes of this study, the procedure that was performed with the highest estimated risk of death or serious complication (DSC) will be denoted at the time of second registration as the “index procedure” performed during the “index surgery”
- Elective surgery =< 30 days after first registration
Exclusion Criteria
- FIRST REGISTRATION-EXCLUSION:
- Any condition that might interfere with the subject’s participation in the study, compliance with study requirements, or in the evaluation of the study results
- SECOND REGISTRATION-EXCLUSION:
- This includes patients whose scheduled procedure was suspended due to unexpected findings, such as carcinomatosis
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05454280.
Locations matching your search criteria
United States
Pennsylvania
Philadelphia
PRIMARY OBJECTIVE:
I. To determine if intensified post-discharge surveillance leads to a 7% absolute risk reduction/35% relative risk reduction in the composite endpoint of 30-day rate of readmission/visit to emergency department/death compared to standard post discharge management in patients undergoing elective, high risk cancer operations.
SECONDARY OBJECTIVES:
I. To determine whether intensified post-discharge surveillance leads to a reduction in:
Ia. 30-day rate of death;
Ib. 30-day rate of hospital readmission after index surgery;
Ic. 30-day rate of unplanned Emergency Department visits.
EXPLORATORY OBJECTIVE:
I. To determine whether this intervention leads to an increase in:
Ia. 30-day rate of receipt of anti-neoplastic therapy after index surgery.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A: Patients undergo scheduled major cancer surgery. Patients then undergo standard of care televisits with a transitional care clinic nurse or clinical research nurse or on day 1 after surgery.
ARM B: Patients undergo scheduled major cancer surgery. Patients then undergo standard of care televisits with a transitional care clinic nurse or clinical research nurse and receive a plan for home health on day 1 after surgery, receive televisit with surgeon, a physician assistant, or a nurse practitioner 3- 5 days after surgery, and receive televisit with transitional care clinic nurse or clinical research nurse again on day 7 after surgery.
Trial PhasePhase III
Trial Typetreatment
Lead OrganizationFox Chase Cancer Center
Principal InvestigatorJason Castellanos
- Primary ID22-1013
- Secondary IDsNCI-2022-08025, SURG-210
- ClinicalTrials.gov IDNCT05454280